Inhibikase Therapeutics (IKT) Accounts Payables (2020 - 2026)
Inhibikase Therapeutics' Accounts Payables was $991,720 in Q2 2026, down 63.3% from $2.7 million a year earlier and down 37.5% from the prior quarter.
Powered by 
Analysis
Inhibikase Therapeutics (IKT) Accounts Payables (2020 - 2026) Analysis & Trends
At the end of FY2025, Accounts Payables at Inhibikase Therapeutics came in at $1.16 million, up 22.8% from FY2024.
- Accounts Payables shows a five-year compound annual growth rate of -7.6% (FY2020 to FY2025).
- In earlier years, Accounts Payables was $943,019 in FY2024 (+45.8%), $646,767 in FY2023 (-43.8%), $1.15 million in FY2022 (+5.6%) and $1.09 million in FY2021 (-36.7%).
- Quarterly Accounts Payables has moved between $620,528 (Q3 2025) and $21.76 million (Q1 2023) over five years.
- Compared with a year earlier, Accounts Payables was higher in three of the last eight quarters, with an average decline of 15.4%.
- The best year-over-year quarter for Accounts Payables over five years was Q3 2022 (growth of 744.0%); the worst was Q3 2023 (a decline of 90.5%).
- Per Business Quant data, IKT's Accounts Payables in the three quarters before Q2 2026 was $1.59 million (Q1 2026), $1.16 million (Q4 2025) and $620,528 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Inhibikase Therapeutics | 359.62 Mn | -225.86 Mn | - | 991,720.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 991,720.00 |
| Mar 31, 2026 | 1.59 Mn |
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | 620,528.00 |
| Jun 30, 2025 | 2.70 Mn |
| Mar 31, 2025 | 1.69 Mn |
| Dec 31, 2024 | 943,019.00 |
| Sep 30, 2024 | 2.53 Mn |
| Jun 30, 2024 | 3.38 Mn |
| Mar 31, 2024 | 3.80 Mn |
| Dec 31, 2023 | 646,767.00 |
| Sep 30, 2023 | 1.97 Mn |
| Jun 30, 2023 | 19.03 Mn |
| Mar 31, 2023 | 21.76 Mn |
| Dec 31, 2022 | 1.15 Mn |
| Sep 30, 2022 | 20.75 Mn |
| Jun 30, 2022 | 4.49 Mn |
| Mar 31, 2022 | 4.38 Mn |
| Dec 31, 2021 | 1.09 Mn |
| Sep 30, 2021 | 2.46 Mn |
API Access
Inhibikase Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=IKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "IKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=IKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();